Literature DB >> 12457004

Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease.

Mitsuhiro Tsukino1, Koichi Nishimura, Stephen P McKenna, Akihiko Ikeda, Takashi Hajiro, Min Zhang, Takateru Izumi.   

Abstract

BACKGROUND: Although the health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) has been assessed by generic or disease-specific HRQoL measures, the responsiveness of the generic HRQoL measures is generally weak.
OBJECTIVES: To investigate the responses generated by generic and disease-specific HRQoL questionnaires, we prospectively followed the clinical course of patients with newly detected COPD after the initiation of treatment.
METHODS: A prospective, longitudinal study with a 1-year follow-up was designed. The forced expiratory volume in 1 s (FEV(1)), forced vital capacity (FVC), the Nottingham Health Profile (NHP) as a generic HRQoL measure, and the Chronic Respiratory Disease Questionnaire (CRQ) as a disease-specific HRQoL measure were measured at baseline and at 3, 6, and 12 months after the initiation of standard treatment.
RESULTS: Eighty-two patients completed the study. The FEV(1), FVC, and NHP and CRQ scores improved significantly during the first 3 months (p < 0.05). During the last 6 months, although the FEV(1) declined (p < 0.05), the HRQoL assessed by the NHP and CRQ remained elevated. Except for the score on the social isolation section of the NHP at 12 months, all HRQoL scores at 6 and 12 months were significantly improved compared to baseline (p < 0.05).
CONCLUSION: In new patients with COPD, the NHP as well as the CRQ was able to detect changes in the HRQoL associated with effective medical interventions. The influence of the changes in airflow limitation on the HRQoL was weak. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12457004     DOI: 10.1159/000066456

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

1.  Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

Authors:  Adam Lowy; Jürg Bernhard
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

2.  Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.

Authors:  Paul W Jones; Julie A Anderson; Peter Ma Calverley; Bartolome R Celli; Gary T Ferguson; Christine Jenkins; Julie C Yates; Jørgen Vestbo; Michael D Spencer
Journal:  Respir Res       Date:  2011-05-31

3.  Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study.

Authors:  Sarah Wilke; Daisy J A Janssen; Emiel F M Wouters; Jos M G A Schols; Frits M E Franssen; Martijn A Spruit
Journal:  Health Qual Life Outcomes       Date:  2012-08-21       Impact factor: 3.186

4.  Reliability and validity of functional health status and health-related quality of life questionnaires in children with recurrent acute otitis media.

Authors:  Carole N M Brouwer; Anne G M Schilder; Henk F van Stel; Maroeska M Rovers; Reinier H Veenhoven; Diederick E Grobbee; Elisabeth A M Sanders; A Rianne Maillé
Journal:  Qual Life Res       Date:  2007-08-01       Impact factor: 4.147

5.  Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies.

Authors:  Milo A Puhan; Michaela Behnke; Martin Frey; Thomas Grueter; Otto Brandli; Alfred Lichtenschopf; Gordon H Guyatt; Holger J Schunemann
Journal:  Health Qual Life Outcomes       Date:  2004-01-08       Impact factor: 3.186

6.  Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population.

Authors:  Margarethe E Wacker; Matthias Hunger; Stefan Karrasch; Joachim Heinrich; Annette Peters; Holger Schulz; Rolf Holle
Journal:  BMC Pulm Med       Date:  2014-08-09       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.